Duncan Higgons
Chief Operating Officer
HEPTARES
Switzerland
Biography
Duncan is the Chief Operating Officer of Agios Pharmaceuticals, Inc., which he joined in 2009. Prior to this, he worked at Archemix Corporation from 2006 to 2009 where he most recently served as President, Chief Operating Officer and interim Chief Executive Officer. Prior to Archemix, Duncan served as the Chief Commercial Officer at TransForm Pharmaceuticals, Inc., a privately-held biotechnology company which was acquired by Johnson & Johnson Company. Previously he held senior business and commercial positions at Alkermes, Eli Lilly and Baxter. He holds a BSc in Mathematics from King's College University of London and an MSc in Economics from London Business School.
Research Interest
business and management
